Neuronostics Limited
Registered name: NEURONOSTICS LIMITED
Neuronostics Limited made £300k revenue and a £595k loss in the year to 31 Dec 2025.
Neuronostics Limited’s revenue grew 188% to £300k in the year to 31 Dec 2025, with a loss of £595k and 17 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Bristol; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Bristol, South West
- Age
- 8 yrs · since 2017
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | Profit only | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £104k | £300k |
| Operating profit | — | — | −£510k | −£800k |
| Profit before tax | — | — | −£504k | −£796k |
| Profit after tax | — | −£665k | −£454k | −£595k |
| Profit (best available) | — | −£665k | −£454k | −£595k |
| Employees (average) | 11 | 11 | 13 | 17 |
| Ratios | ||||
| Profit margin | — | — | −434.7% | −198.1% |
| Revenue per employee | — | — | £8k | £17.7k |
| Profit per employee | — | −£60.4k | −£34.9k | −£35k |
| Growth (year on year) | ||||
| Revenue growth | — | — | — | ▲187.7% |
| Headcount growth | — | 0% | ▲18.2% | ▲30.8% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £96.8k | £734k | — | — |
| Net assets | £70.1k | £755k | £730k | £189k |
| Fixed assets | £33.8k | £51.7k | — | — |
| Current assets | £196k | £789k | — | — |
| Debtors | £99k | £55.3k | £6.2k | £9.6k |
| Source | Accounts · bulk data Mar 2024 | Accounts · bulk data Mar 2024 | FullAccounts · bulk data Mar 2025 | FullAccounts · bulk data Jul 2026 |
How the business works
- Profit margin
- −198.1%
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £17.7k
- Revenue ÷ average employees.
- Profit per employee
- −£35k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 3.2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼74%
- Now £189k
- Cash at bank
- —
- Now —
- Headcount
- ▲31%
- Now 17
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Sharp Life Science (EU) LimitedUxbridge · Other research and experimental development on natural sciences and engineering
- Revenue
- £269k
- Profit
- £178k
- Staff
- 0
- Creative Tech (UK) LimitedLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £462k
- Profit
- £75.8k
- Staff
- 5
- Good Homes Alliance CICBognor Regis · Other research and experimental development on natural sciences and engineering
- Revenue
- £186k
- Profit
- £9.2k
- Staff
- 4
- Crystogen LtdManchester · Other research and experimental development on natural sciences and engineering
- Revenue
- £163k
- Profit
- £48.2k
- Staff
- 2
- GT Diagnostics (UK) LimitedLondon · Other research and experimental development on natural sciences and engineering
- Revenue
- £712k
- Profit
- £42.3k
- Staff
- 3
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£595k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.